GoodRx Holdings, Inc.

Total Valuation

GoodRx Holdings, Inc. carries a market capitalization of 1.02B, placing it among publicly traded companies globally. Its enterprise value stands at 983.87M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Share Statistics

GoodRx Holdings, Inc. currently has 337.58M shares outstanding.

Valuation Ratios

GoodRx Holdings, Inc. trades at a trailing price-to-earnings ratio of 32.99. The price-to-sales ratio is 0.86, and the price-to-book ratio stands at -0.48.

Enterprise Valuation

On an enterprise value basis, GoodRx Holdings, Inc. trades at an EV/EBITDA multiple of 5.99 and an EV/FCF ratio of 5.08. The EV/Sales ratio of 1.25 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 12.59 provides insight into valuation relative to core operating earnings.

Financial Position

GoodRx Holdings, Inc. maintains a current ratio of 1.47, meaning it holds 1.5x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 87.04, indicating elevated leverage, while an interest coverage ratio of 3.94 demonstrates adequate ability to service its debt obligations.

Financial Efficiency

Taxes

Over the trailing twelve months, GoodRx Holdings, Inc. has paid 24.95M in income taxes, reflecting an effective tax rate of 54.83.

Stock Price Statistics

GoodRx Holdings, Inc.'s stock has declined approximately -25.1269% over the past 52 weeks. The 50-day moving average sits at 2.40, while the 200-day moving average is 2.98.

Income Statement

Over the trailing twelve months, GoodRx Holdings, Inc. generated 787.89M in revenue and converted that into 20.56M in net income, yielding earnings per share of 0.06. EBITDA reached 164.22M, while operating income came in at 78.12M.

Balance Sheet

GoodRx Holdings, Inc. holds 235.71M in cash and equivalents against 541.35M in total debt, resulting in a net debt position of 251.71M. Total book value stands at -1.41B, with working capital of 407.27M providing operational flexibility.

Cash Flow

GoodRx Holdings, Inc. produced 170.33M in operating cash flow over the past twelve months. After subtracting -4.51M in capital expenditures, free cash flow totaled 165.81M - equivalent to 0.48 per share.

Margins

GoodRx Holdings, Inc. operates with a gross margin of 91.83, reflecting its pricing power and cost economics. The operating margin of 9.92 and net profit margin of 2.61 provide insight into operational efficiency.

Dividends & Yields

Scores

GoodRx Holdings, Inc. posts an Altman Z-Score of -0.02, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.